Document is current
Any future updates will be listed below
-
Authors
Greimel, Antonia
Habler, Katharina
Gräfe, Caroline
Maciuga, Nils
Brozat, Clara Isabell
Vogeser, Michael
Zoller, Michael
Happich, Felix L.
Liebchen, Uwe
Frank, Sandra
Paal, Michael
Scharf, Christina
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04913298 at ClinicalTrials.govDocuments that mention this clinical trial
Extracorporeal adsorption of protective and toxic bile acids and bilirubin in patients with cholestatic liver dysfunction: a prospective study
https://doi.org/10.1186/s13613-023-01198-7
Extracorporeal Elimination of Pro- and Anti-inflammatory Modulators by the Cytokine Adsorber CytoSorb® in Patients with Hyperinflammation: A Prospective Study
https://doi.org/10.1007/s40121-024-01028-8
-
Funding
Funding for this research was provided by:
Else Kröner-Fresenius-Stiftung (2021_EKEA.101)
Universitätsklinik München
- License Information
-
More Information
Article History
Received: 14 June 2023
Accepted: 27 September 2023
First Online: 9 November 2023
Declarations
:
: Ethical approval was obtained from the ethical review committee of the Ludwig-Maximilians-Universität (registration number 21-236).
: Not applicable.
: CS got speaker fees from CytoSorbents Europe GmbH. UL and MZ received consulting honoraries from CytoSorbents Europe GmbH.
